ESC 365 - Impact on atrial remodeling of dapagliflozin in patients with heart failure: MODA study. rational and design.

HFA Premium Access

Impact on atrial remodeling of dapagliflozin in patients with heart failure: MODA study. rational and design.

Session: ePosters in chronic heart failure - heart failure with reduced ejection fraction (HFrEF) 1

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Mr A. Riquelme Perez (Murcia, ES)

Event: Heart Failure 2023

Congress Presentation

About the speaker

Mr Alejandro Riquelme Perez

University of Murcia, Murcia (Spain)

0 follower

5 more presentations in this session

CPET parameters correlation to Exercise Echocardiographic characteristics in patients with diastolic dysfunction

Speaker: Doctor B. Son (Daegu, KR)

Implementation of the european society cardiac amyloidosis diagnostic algorithm for transthyretin amyloid cardiomyopathy: First real-world data on a heart failure unit in Colombia.

Speaker: Doctor A. Rodriguez (Bogota, CO)

Utility of left ventricular isovolumic contraction velocity in patients with heart failure with preserved ejection fraction

Speaker: Doctor T. Kawata (Tokyo, JP)

Impact on atrial remodeling of dapagliflozin in patients with heart failure (MODA TRIAL): baseline echo characteristics according to LVEF phenotypes

Speaker: Mr A. Riquelme Perez (Murcia, ES)

Impact on atrial remodeling of dapagliflozin in patients with heart failure (MODA TRIAL): baseline clinical characteristics

Speaker: Mr A. Riquelme Perez (Murcia, ES)

Access the full session

ePosters in chronic heart failure - heart failure with reduced ejection fraction (HFrEF) 1

Speakers: Mr A. Riquelme Perez, Doctor B. Son, Doctor A. Rodriguez, Doctor T. Kawata, Mr A. Riquelme Perez...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by